Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays

PLoS Medicine

Volumn 2, Issue 8, 2005, Pages 0771-0787

  Costello, Christine M ^a,f   Mah, Nancy ^a   Häsler, Robert ^a   Rosenstiel, Philip ^a   Waetzig, Georg H ^b   Hahn, Andreas ^c   Lu, Tim ^a   Gurbuz, Yesim ^d   Nikolaus, Susanna ^d   Albrecht, Mario ^c   Hampe, Jochen ^a   Lucius, Ralph ^d   Klöppel, Günther ^d   Eickhoff, Holger ^e,g   Lehrach, Hans ^e   Lengauer, Thomas ^c   Schreiber, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b CONARIS Research Institute ^*  (Germany)

^c MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g SCIENION AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; COMPLEMENTARY DNA; MESALAZINE; TRANSCRIPTOME; CD66 ANTIGENS; CELL ADHESION MOLECULE; CYLD PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN KINASE C; PROTEIN KINASE C BETA; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DNA MICROARRAY; ENTERITIS; EPITHELIUM CELL; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGMOID; ULCERATIVE COLITIS; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CELL ADHESION MOLECULES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASE C; TUMOR SUPPRESSOR PROTEINS;

EID: 33644847555     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020199     Document Type: Article

References (60)

1. Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M (2005) Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6: 376-388.
2. Podolsky DK (1991) Inflammatory bowel disease (1). N Engl J Med 325: 928-937.
3. Bonen DK, Cho JH (2003) The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536.
4. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
5. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
6. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, et al. (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357: 1925-1928.
7. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, et al. (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36: 476-480.
8. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36: 471-475.
9. van Dullemen HM, de Jong E, Slors F, Tytgat GN, van Deventer SJ (1998) Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: Report of two cases. Dis Colon Rectum 41: 98-102.
10. Hillier LD, Lennon G, Becker M, Bonaldo MF, Chiapelli B, et al. (1996) Generation and analysis of 280,000 human expressed sequence tags. Genome Res 6: 807-828.
11. Lawrance IC, Fiocchi C, Chakravarti S (2001) Ulcerative colitis and Crohn's disease: Distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10: 445-456.
12. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA (2000) Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 4: 1-11.
13. Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, et al. (2004) Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: Screening by DNA microarrays. Inflamm Bowel Dis 10: 1-14.
14. Mah N, Thelin A, Lu T, Nikolaus S, Kuhbacher T, et al. (2004) A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics 16: 361-370.
15. Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70: 439-444.
16. Rachmilewitz D (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. BMJ 298: 82-86.
17. Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 4947: 1041-1048.
18. Bates MD, Erwin CR, Sanford LP, Wiginton D, Bezerra JA, et al. (2002) Novel genes and functional relationships in the adult mouse gastrointestinal tract identified by microarray analysis. Gastroenterology 122: 1467-1482.
19. Boer JM, Huber WK, Sultmann H, Wilmer F, von Heydebreck A, et al. (2001) Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 11: 1861-1870.
20. Hoyle DC, Rattray M, Jupp R, Brass A (2002) Making sense of microarray data distributions. Bioinformatics 18: 576-584.
21. Lu T, Costello CM, Croucher PJ, Hasler R, Deuschl G, et al. (2005) Can Zipf's law be adapted to normalize microarrays? BMC Bioinformatics 6: 37.
22. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM (1999) Systematic determination of genetic network architecture. Nat Genet 22: 281-285.
23. Boguski MS, Lowe TM, Tolstoshev CM (1993) dbEST - Database for "expressed sequence tags." Nat Genet 4: 332-333.
24. Halgren RG, Fielden MR, Fong CJ, Zacharewski TR (2001) Assessment of clone identity and sequence fidelity for 1,189 IMAGE cDNA clones. Nucleic Acids Res 29: 582-588.
25. Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S (2002) p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 168: 5342-5351.
26. Zhang W, Morris QD, Chang R, Shai O, Bakowski MA, et al. (2004) The functional landscape of mouse gene expression. J Biol 3: 21.
27. Geboes K (2004) Is histology useful for the assessment of the efficacy of immunosuppressive agents in IBD and if so, how should it be applied ? Acta Gastroenterol Belg 67: 285-289.
28. Fraser AG, Marcotte EM (2004) A probabilistic view of gene function. Nat Genet 36: 559-564.
29. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2: 998-1004.
30. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, et al. (1998) Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 357-369.
31. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484.
32. Jono H, Lim JH, Chen LF, Xu H, Trompouki E, et al. (2004) NF-kB is essential for induction of CYLD, the negative regulator of NF-kB: Evidence for a novel inducible auto-regulatory feedback pathway. J Biol Chem 28: 28.
33. Dijkstra G, van Goor H, Jansen PL, Moshage H (2004) Targeting nitric oxide in the gastrointestinal tract. Curr Opin Investig Drugs 5: 529-536.
34. Iijima H, Neurath MF, Nagaishi T, Glickman JN, Nieuwenhuis EE, et al. (2004) Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J Exp Med 199: 471-482.
35. Rubel C, Fernandez GC, Dran G, Bompadre MB, Isturiz MA, et al. (2001) Fibrinogen promotes neutrophil activation and delays apoptosis. J Immunol 166: 2002-2010.
36. Ergun S, Kilik N, Ziegeler G, Hansen A, Nollau P, et al. (2000) CEA-related cell adhesion molecule 1: A potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 5: 311-320.
37. Hauck CR (2002) Cell adhesion receptors - Signaling capacity and exploitation by bacterial pathogens. Med Microbiol Immunol (Berl) 191: 55-62.
38. Dignass AU (2001) Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 7: 68-77.
39. Kuper H, Adami HO, Trichopoulos D (2000) Infections as a major preventable cause of human cancer. J Intern Med 248: 171-183.
40. Edwards FC, Truelove SC (1963) The course and prognosis of ulcerative colitis. Gut 41: 299-315.
41. Brostrom O, Lofberg R, Nordenvall B, Ost A, Hellers G (1987) The risk of colorectal cancer in ulcerative colitis. An epidemiological study. Scand J Gastroenterol 22: 1193-1199.
42. Joaquin M, Watson RJ (2003) The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain. J Biol Chem 278: 44255-44264.
43. Komatsu K, Murata K, Kameyama M, Ayaki M, Mukai M, et al. (2002) Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. Oncology 63: 192-200.
44. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279: 5059-5065.
45. 2+-binding S100 proteins. Histol Histopathol 16: 707-712.
46. Vizoso FJ, Fagilde MC, Corte MD, Corte MG, Gava R, et al. (2003) Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: Clinical significance and relationship with steroid receptors. Int J Biol Markers 18: 301-310.
47. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, et al. (1996) Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262.
48. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, et al. (2002) Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: A molecular switch for the Wnt pathway. Genes Dev 16: 1066-1076.
49. Liu C, Li Y, Semenov M, Han C, Baeg GH, et al. (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847.
50. van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB (2002) . van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB (2002) Malignancies in inflammatory bowel disease: Fact or fiction? Scand J Gastroenterol (Suppl): 48-53.
51. Wyatt J, Oberhuber G, Pongratz S, Puspok A, Moser G, et al. (1997) Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol 92: 1891-1896.
52. Wakabayashi M, Ito T, Mitsushima M, Aizawa S, Ueda K, et al. (2003) Interaction of lp-dlg/KIAA0583, a membrane-associated guanylate kinase family protein, with vinexin and beta-catenin at sites of cell-cell contact. J Biol Chem 278: 21709-21714.
53. Humbert P, Russell S, Richardson H (2003) Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer. Bioessays 25: 542-553.
54. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A (2001) Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159: 2001-2009.
55. Massova I, Kotra LP, Fridman R, Mobashery S (1998) Matrix metalloproteinases: Structures, evolution, and diversification. FASEB J 12: 1075-1095.
56. von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47: 63-73.
57. Carraway KL, Ramsauer VP, Haq B, Carothers Carraway CA (2003) Cell signaling through membrane mucins. Bioessays 25: 66-71.
58. Wilson AJ, Gibson PR (1997) Epithelial migration in the colon: Filling in the gaps. Clin Sci (Lond) 93: 97-108.
59. Kuroda Si, Tokunaga C, Kiyohara Y, Higuchi O, Konishi H, et al. (1996) Protein-protein interaction of zinc finger LIM domains with protein kinase C. J Biol Chem 271: 31029-31032.
60. Nakagawa N, Hoshijima M, Oyasu M, Saito N, Tanizawa K, et al. (2000) ENH, containing PDZ and LIM domains, heart/skeletal muscle-specific protein, associates with cytoskeletal proteins through the PDZ domain. Biochem Biophys Res Commun 272: 505-512.